Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a page revision tag: Revision: v3.3.4, and removed related topics including 'Multiple Myeloma', 'MedlinePlus Genetics', and the prior revision tag 'Revision: v3.3.3'. The primary study details are unaffected.
    Difference
    0.2%
    Check dated 2026-01-15T10:46:16.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and a MedlinePlus Genetics link in the Related Topics section.
    Difference
    0.2%
    Check dated 2026-01-01T03:45:57.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a new footer/version label 'Revision: v3.3.3' and removes ancillary footer links like HHS Vulnerability Disclosure and MedlinePlus Genetics; these changes affect navigation and metadata but do not alter study details or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-12-17T20:25:15.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Publication section now includes a note that items are automatically filled from PubMed and may not be about the study. The revision version has been updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T13:52:33.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The government funding/operating-status notice at the bottom of the page was removed, removing guidance about potential site-wide delays and where to check for updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T08:38:36.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The two screenshots show only minor layout and formatting adjustments to the study details page, with no changes to core study content (title, identifiers, eligibility criteria, design, or outcome measures). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T05:13:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.